Laboratorio Reig Jofre (XMAD:RJF) YoY EBITDA Growth : 8.60% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Laboratorio Reig Jofre's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 8.60%.

Laboratorio Reig Jofre's EBITDA per Share for the three months ended in Dec. 2023 was €0.10.

Laboratorio Reig Jofre YoY EBITDA Growth Historical Data

The historical data trend for Laboratorio Reig Jofre's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre YoY EBITDA Growth Chart

Laboratorio Reig Jofre Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

16.79

0.64

22.86

12.66

Laboratorio Reig Jofre Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															57.63	36.78	-100.00	-	8.60

Laboratorio Reig Jofre YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Laboratorio Reig Jofre's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.436	-	0.387)	/	\| 0.387 \|
=	12.66 %

Laboratorio Reig Jofre's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Sep. 2022 ))	/	\| EBITDA per Share (Q: Sep. 2022 )) \|
=	(0.101	-	0.093)	/	\| 0.093 \|
=	8.60 %

Laboratorio Reig Jofre YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Reig Jofre (XMAD:RJF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

FEQ1:Germany

Address

Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970

Website

http://www.reigjofre.com

Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.